Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
Diego Scheggia(Ospedale San Paolo), Francesco Papaleo(Italian Institute of Technology), Simone Guadagna(Italian Institute of Technology), Joel E. Kleinman(Johns Hopkins University), Marco Armando(Bambino Gesù Children's Hospital), Carlo Caltagirone(Fondazione Santa Lucia), Fabrizio Piras(Fondazione Santa Lucia), Maddalena Mereu(University of Padua), Daniel R. Weinberger(Johns Hopkins University), Maria Pontillo(Bambino Gesù Children's Hospital), Thomas M. Hyde(Johns Hopkins University), Sara Sannino(Italian Institute of Technology), Sanne S. Kaalund(University of Cambridge), Rosa Mastrogiacomo(Italian Institute of Technology), Maria Antonietta De Luca(University of Hertfordshire), Emiliana Borrelli(University of Calabria), Richard E. Straub(Lieber Institute for Brain Development), Stefano Vicari(Bambino Gesù Children's Hospital), Francesca Managò(Italian Institute of Technology), Gianfranco Spalletta(University of Zurich), Fengyu Zhang(Center for Human Genetics), Genny Orso(University of Padua)
Cited by 43
Related Papers
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
|The American Journal of Human Genetics|2003|1.1k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
|Brain|2009|962
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|702